Abstracts
Late-breaking abstracts
LBA4 - Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Pooled analysis of STARTRK-2, STARTRK-1, and ALKA-372-001

https://doi.org/10.1093/annonc/mdy483.003Get rights and content
Under an Elsevier user license
open archive

Cited by (0)